☰

Xiaocang Lin, Ph.D. - Publications

Affiliations: 
2000 Harvard University, Cambridge, MA, United States 
Tree Info Similar researchers PubMed Report error

3 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2015 Phan L, Chou PC, Velazquez-Torres G, Samudio I, Parreno K, Huang Y, Tseng C, Vu T, Gully C, Su CH, Wang E, Chen J, Choi HH, Fuentes-Mattei E, Shin JH, ... ... Lin X, et al. The cell cycle regulator 14-3-3σ opposes and reverses cancer metabolic reprogramming. Nature Communications. 6: 7530. PMID 26179207 DOI: 10.1038/Ncomms8530  0.413
2013 Xia Y, Yang W, Bu W, Ji H, Zhao X, Zheng Y, Lin X, Li Y, Lu Z. Differential regulation of c-Jun protein plays an instrumental role in chemoresistance of cancer cells. The Journal of Biological Chemistry. 288: 19321-9. PMID 23678002 DOI: 10.1074/Jbc.M113.475442  0.443
2009 Yang WL, Wang J, Chan CH, Lee SW, Campos AD, Lamothe B, Hur L, Grabiner BC, Lin X, Darnay BG, Lin HK. The E3 ligase TRAF6 regulates Akt ubiquitination and activation. Science (New York, N.Y.). 325: 1134-8. PMID 19713527 DOI: 10.1126/science.1175065  0.426
Show low-probability matches.